Numerous ex vivo experiments are underway by using Stealth RNA Vector (SRV) in research and development for direct reprogramming from fibroblasts and/or peripheral blood monocytes into induced pluripotent stem cells (iPSC) and various cells. TOKIWA-Bio is actively working on the development of Stealth RNA Vector (SRV) directly in vivo as a future regenerative medicine.